Additionally, thrombin-sensitive protein 1 (TSP1), abnormal complement regulation, anti-endothelial cell antibody (AE-CA), and excessive release of VWF multimers have been associated with the onset of TTP (4). The gene discussed is VWF; the disease is thrombotic thrombocytopenic purpura.